Important safety considerations include gastrointestinal side effects (nausea, vomiting, diarrhoea), risk of gallbladder disease, pancreatitis, dehydration leading to acute kidney injury, and worsening diabetic retinopathy with rapid glycaemic improvement
The audience clapped and whooped
Trust in our services grows from our consistent dedication to safe practices
10.3389/FNUT.2022.1022650 Summary Keywords papillary thyroid cancer, DPP-IV, Isglt2, adjuvant therapy, thyroid cancer Citation Buczyska A, Kociuszko M, Krtowski AJ and Popawska-Kita A (2024) Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review
By slowing digestion and increasing feelings of fullness, these medications help people eat less and lose weight over time